NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
CHAMPIONING THE MISSIONS THAT MATTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CHAMPIONING THE MISSIONS THAT MATTER
ST13
US500000099277109Class
42
Filing
99277109
Registration
8339248
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
07/07/2026
Trademark type
Word
Nice classes
42
Filing date
07/10/2025
Registration date
07/07/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/28/2025
First use in commerce
10/28/2025
Drawing code
4
Owner type
16
Owner location
Bridgewater, NJ, US
Examiner
DAHLING, KRISTIN M
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
R.P. SCHERER TECHNOLOGIES, LLC
Representatives
Vanessa A. Ignacio, Esq. Lowenstein Sandler LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical drug development services; Pharmaceutical research and development; Product development in the field of pharmaceuticalsbiopharmaceuticalsradiopharmaceuticalspharmaceutical preparationsvitaminsmedicinespharmaceutical packaging and drug delivery technologies; Research and development of new products for others; Product development consultation; Testing of pharmaceuticals; Scientific research consulting in the field of pharmaceuticals and biopharmaceuticals; Technology consultation in the field of pharmaceuticals and new drug development; Custom design and development of chemical reagents and biochemical assays; Development of pharmaceuticals for cell and gene therapies; Research and development and consultation related thereto in the field of over-the-counter drugs; Research and development in the field of pharmaceutical preparations and products for cell therapygene therapybeauty care; Scientific research consulting; Technology consultation in the field of new drug development for the pharmaceutical industry; Technology consultation in the field of pharmaceutical drug delivery and dosage technologies; Scientific research consulting in the field of pharmaceutical drug delivery and dosage technologies
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/18/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/18/2026
DOCK
ASSIGNED TO EXAMINER
06/18/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/12/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/12/2026
IUAF
USE AMENDMENT FILED
03/04/2026
EISU
TEAS STATEMENT OF USE RECEIVED
03/04/2026
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/24/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/30/2025
PUBO
PUBLISHED FOR OPPOSITION
12/30/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/24/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2025
DOCK
ASSIGNED TO EXAMINER
12/01/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2025
NWAP
NEW APPLICATION ENTERED
07/10/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/10/2025
Continuous trademark protection
Get notified about every new filing that threatens CHAMPIONING THE MISSIONS THAT MATTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.